This study aimed to understand the testimonies of disabled people about the concreteness of the social inclusion process, as well as to articulate their testimonies with the directives of Law 3289/99. Eighteen people were interviewed, six of which were physically disabled, six visually disabled, and six had hearing disabilities. Data were standardized and categorized in two meaning cores: pre-inclusivist and inclusivist guidelines of the disabled person. The methodological perspective was discourse analysis. In conclusion, these subjects had achievements in legislation that guarantees their rights to citizenship, but there are challenges in the areas of healthcare, education, professional training and insertion in the job market. The rehabilitation nurses must know the experiences of these subjects and their relatives to help them with strategies of coping for the problems affecting their inclusion, and consequently their health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0080-62342009000100023 | DOI Listing |
Am J Speech Lang Pathol
January 2025
Allina Health, Courage Kenny Rehabilitation Institute, Minneapolis, MN.
Purpose: Traumatic brain injury (TBI) is a life-altering event that can abruptly and drastically derail an individual's expected life trajectory. While some adults who have sustained a TBI go on to make a full recovery, many live with persisting disability many years postinjury. Helping patients adjust to and flourish with disability that may persist should be as much a part of rehabilitative practice as addressing impairment, activity, and participation-level changes after TBI.
View Article and Find Full Text PDFPLoS One
January 2025
Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Onychomycosis is a common, difficult to treat nail disorder. Our objective was to explore disparities in current clinical management practices for onychomycosis in patients from underrepresented groups and with specific comorbidities. We conducted a cross-sectional study using the All of Us (AoU) research program.
View Article and Find Full Text PDFAndes Pediatr
August 2023
Facultad de Medicina Humana, Universidad de Piura, Lima, Peru.
Unlabelled: Effective Verbal Communication (EVC) is the ability to understand and say what children feel and think, which could be affected by anemia.
Objective: to determine the association between anemia and EVC at a comprehensive and expressive level according to age in children from 9 to 36 months.
Subjects And Method: study based on the 2020 Demographic and Family Health Survey of Peru, using a cross-sectional design.
Eur J Pediatr
January 2025
CESTA VON, Bratislava, Slovakia.
Unlabelled: High rates of childhood neurodisability are reported among the Roma, Europe's largest ethnic minority community. Interventions targeting early child development (ECD) during the first 2 years of life can improve neurodevelopmental outcomes in vulnerable children; however, evidence from Roma preschoolers is scarce. In a quasi-experimental observational study, we compared neurodevelopmental outcomes at age 2 years, measured on the INTERGROWTH-21st Project Neurodevelopmental Assessment (INTER-NDA), between Roma children receiving a community-based ECD intervention (RI, n = 98), and age- and sex-matched Roma and non-Roma children (RC, n = 99 and NRC, n = 54, respectively) who did not receive the intervention in Eastern Slovakia.
View Article and Find Full Text PDFTurk J Pediatr
December 2024
Department of Pediatric Neurology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University Faculty of Medicine, Ankara, Türkiye.
Background: Metoclopramide, a dopamine antagonist employed for its antiemetic effects, can precipitate neuropsychiatric adverse effects, including extrapyramidal symptoms and, in a few instances, acute psychosis. Although there have been reports of metoclopramide-induced psychosis in elderly individuals, there is no documentation of such incidents in children as far as we are aware.
Case Presentation: This case report describes an 11-year-old girl with a history of mild intellectual disability and attention deficit hyperactivity disorder, managed with 10 mg of methylphenidate daily.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!